BONTAC is looking forward to your arrival at Booth No. 3A53 in 2024 PCHi
On March 20~22, 2024, Personal Care & Home Ingredients Shanghai (PCHi) will be held in Shanghai World Expo Exhibition & Convention Center. BONTAC’s active raw materials for high-end cosmetics will be displayed at Booth No. 3A53 in 2024 PCHi, including but not limited to NMN, Pro-Xylane, Rare Ginsenoside Rh2/Rg3, Ergothioneine, Salidroside and Type III Recombinant Collagen. BONTAC has been dedicated to provide high-quality raw materials of coenzymes and natural products for 12 years. Looking forward to seeing you at site.
BONTAC Product List
| Niche Area | Products | Application Scope |
| Coenzyme | NMN (CAS No.: 1094-61-7) | Healthcare products; Cosmetics; Medicine |
| NAD (CAS No.: 53-84-9) | Healthcare products; Cosmetics; Diagnostic reagents | |
| Raw materials for enzyme catalysis; Animal health | ||
| Endotoxin-free grade | ||
| NADH (CAS No.: 606-68-98) | Functional food and drink; Biomedical research and development | |
| Healthcare product; Diagnostic reagents | ||
| NADP (CAS No.: 24292-60-2/1184-16-3) | Raw materials for medicine or enzyme catalysis; Diagnostic reagents; | |
| In vitro diagnostic reagents (GR); Biomedical research and development | ||
| S-NAD (CAS No.: 4090-29-3) | Biochemical diagnostic reagents | |
| NR (CAS No.: 23111-00-4) | Healthcare products; Cosmetics; Diagnostic reagent | |
| Natural products | Ginsenoside Rh2 (CAS No.：78214-33-2) |
Healthcare products; Cosmetics; Drink; Alcohol; Medicine; Functional food |
| Ginsenoside Rg3 (Cas No. : 38243-03-7) |
||
| Salidroside (Cas No.: 10338-51-9) | Healthcare products; Scientific research experiment; New drug development | |
| Stevia Sweetener (RD) (Cas No.: 63279-13-0 ) |
Food; Drink; Daily chemical industry; Brewing | |
| Raw materials for cosmetics | Pro-Xylane (CAS No.: 439685-79-7) | Cosmetics |
| Erythrothioneine | Cosmetics | |
| Dietary supplements | L-Glutathione Reduced | Healthcare products; Cosmetics |
| Resveratrol | Healthcare products; Cosmetics | |
| Phosphatidylserine | Healthcare products; Biochemical diagnostic reagent | |
| Medicine and intermediate | Ursodeoxycholic acid (CAS No.: 128-13-2) |
Healthcare products; Biochemical diagnostic reagent |
| Chenodeoxycholic acid | Healthcare products; Biochemical diagnostic reagent | |
| Cholic acid | Healthcare products; Biochemical diagnostic reagents |
BONTAC profile
Bontac Bio-Engineering (Shenzhen) Co., Ltd. (also referred to as BONTAC) is a high-tech enterprise established in July 2012. BONTAC integrates R&D, production and sales. There are six major series of product in BONTAC, involving coenzymes, natural products, sugar substitutes, cosmetics, dietary supplements and medical intermediates.
BONTAC is the pioneer of NMN industry. By virtue of the first whole-enzyme catalysis technology in China, BONTAC takes the industry lead in its niche field of coenzyme. Our coenzyme products are widely used in health industry, medical & beauty, green agriculture, biomedicine and other fields.
BONTAC adheres to independent innovation, with more than 170 invention patents. Different from the traditional chemical synthesis and fermentation industry, BONTAC has advantages of green low-carbon and high-value-added biosynthesis technology. BONTAC has undertaken a number of provincial and national science projects in China, with the only approved "coenzyme engineering technology research center" in Guangdong China. In the future, BONTAC will continue to build ecological relationship with academia, and upstream/downstream partners, lead the synthetic biological industry and create a better life for human beings.
BONTAC is the pioneer of NMN industry. By virtue of the first whole-enzyme catalysis technology in China, BONTAC takes the industry lead in its niche field of coenzyme. Our coenzyme products are widely used in health industry, medical & beauty, green agriculture, biomedicine and other fields.
BONTAC adheres to independent innovation, with more than 170 invention patents. Different from the traditional chemical synthesis and fermentation industry, BONTAC has advantages of green low-carbon and high-value-added biosynthesis technology. BONTAC has undertaken a number of provincial and national science projects in China, with the only approved "coenzyme engineering technology research center" in Guangdong China. In the future, BONTAC will continue to build ecological relationship with academia, and upstream/downstream partners, lead the synthetic biological industry and create a better life for human beings.
